Chipmunk Health Chooses Philips HealthSuite Digital Platform to Roll Out and Scale Up its Telehealth Services

PhilipsRoyal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced that telehealth service provider Chipmunk Health, with locations in the Netherlands and Canada, is leveraging the capabilities and services of Philips' HealthSuite digital platform to roll out its new GP-to-patient home monitoring solutions.

Designed to allow general practitioners to keep a closer check on the health status of their patients, Chipmunk Health’s telehealth services offer patients a closer relationship with their GP, without the waiting time and inconvenience of having to visit their GP for routine check-ups. The company will use the open, cloud-based infrastructure and services of Philips' HealthSuite digital platform to connect multiple home monitoring devices, aggregate the acquired data via a dedicated smart hub, and securely transmit, store and analyze it.

"Philips' HealthSuite digital platform is a vitally important element in rolling out our new services and scaling them up in a safe and secure way," said Erik Duijsens, founder and CEO of Chipmunk Health. "We are convinced that our consumer-oriented telehealth services will provide more effective and qualitatively better healthcare than we already have, and at lower cost. Patients will be able to access all their health data in one place and doctors will be better equipped to serve their patients' complex needs."

"Many Innovative telehealth start-ups have excellent ideas but don't have the resources to develop the secure, privacy-protected data infrastructure needed to unify and connect devices and data, and securely transmit, store and analyze patient data," said Dale Wiggins, Philips' Business Leader for the HealthSuite digital platform. §Supporting innovative companies like Chipmunk Health is one of the reasons why we made HealthSuite an open digital platform on which third parties can build their own applications. We are delighted that Chipmunk has joined the growing number of companies that recognize the growth and scale-up potential of our platform."

Today's announcement follows similar recent agreements to use Philips' HealthSuite digital platform by eye care provider Alcon, selfcare solutions company Ypsomed, and Internet of Things (IoT) managed service provider Integron. In such collaborations, Philips is the provider of the relevant cloud-based healthcare IT infrastructure and not involved in the commercialization of the products and services of these companies.

About Philips HealthSuite digital platform

Philips' HealthSuite digital platform offers companies Cloud-based services and technical tools that meet privacy, security and regulatory requirements that they can use to develop and run a new generation of connected healthcare applications. Unlike other digital platforms, HealthSuite is purpose-built to solve the complex challenges of healthcare, featuring capabilities to connect devices, collect personal and health data, store and share data securely, analyze data, build and deploy AI models, and create solutions on the Cloud.

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2018 sales of EUR 18.1 billion and employs approximately 77,000 employees with sales and services in more than 100 countries.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...